A customer experienced bleeding after inserting the abbott diabetes care (adc) device.As a result, the customer experienced loss of consciousness and "unresponsive".The customer was seen in a hospital where they obtained laboratory blood glucose readings of 21 mg/dl and unspecified result from a magnetic resonance imaging (mri).The customer received intravenous insulin drip, which had sugar water administered by a healthcare professional for the treatment of hypoglycemia.There was no report of death or permanent impairment associated with this event.
|
Sensor (b)(6) has been returned and investigated.Visual inspection performed on the returned applicator and no issues were observed.Applicator had fired correctly, and no issue was observed with the returned sharp.Visually inspected the sensor and no issues were observed.The sensor plug was properly seated, and no failure modes were observed upon visual inspection of the sensor plug assembly.Performed a visual inspection on the sensor pack revealed damaged to transition features indicating incorrect assembly method by the user.Lid was completely peeled off.Therefore, this issue is not confirmed to use due to incorrect assembly method.An extended investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.The device history records (dhrs) for the fs libre sensor and fs libre sensor kit were reviewed and the dhrs showed the fs libre sensor and sensor kit passed all tests prior to release.All pertinent information available to abbott diabetes care has been submitted.
|